Crossmark

A randomised study to evaluate the potential added value of shared meditation involving people with cancer, health professionals and third persons compared to meditation conducted with patients only: design of the Implic-2 protocol

Crossref DOI link: https://doi.org/10.1186/s12885-024-12521-1

Published Online: 2024-09-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Prevost, Virginie

Tran, Titi

Leconte, Alexandra

Lequesne, Justine

Fernette, Marie

Segura, Carine

Chevigné, Sylvie

Gouriot, Mylène

Clarisse, Bénédicte
License Information

Text and Data Mining valid from 2024-09-04

Version of Record valid from 2024-09-04
More Information

Article History

Received: 7 February 2024

Accepted: 14 June 2024

First Online: 4 September 2024

Declarations

:

: This study received ethical approval from the <i>Comité de Protection des Personnes</i> de <i>Nord-Ouest III</i> on 4 September 2023 (Réf. SI RIPH 2G: 23.02350). The approved protocol version is Version 1.2 dated from 2023/08/29.Information about the study through flyers will be displayed in the centre and outside, indicating the contact details. Interested participants will then be phoned by the clinical research nurse in charge of the study to check their eligibility and give them the study information note. All participants will provide written informed consent before any study procedure.All participants will give their written informed consent before any study-related assessment. The study will be conducted in accordance with the relevant guidelines and regulations.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below